KAM
AGN

Kavi Asset Management’s Allergan plc AGN Stock Holding History

Kavi Asset Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-24,645
Closed -$6.61M – 44
2016
Q1 		$6.61M Sell
24,645
-255
-1% -$73K 5.17% 6
2015
Q4 		$7.78M Buy
+24,900
New +$7.41M 6.41% 5

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Kavi Asset Management's AGN Position: Q2 2016 in Review

Kavi Asset Management sold out of Allergan plc (AGN) in Q2 2016, closing a stake of 24,645 shares — an estimated $6.61M sold.

Kavi Asset Management first reported a position in AGN in Q4 2015 and held it in 2 quarters. The position peaked at $7.78M in Q4 2015. 1,107 funds tracked by Wall St. Rank hold AGN as of Q2 2016.

  • Kavi Asset Management reported no remaining Allergan plc position as of Q2 2016 after selling out during the quarter.
  • Kavi Asset Management sold 24,645 Allergan plc shares in Q2 2016, an estimated $6.61M.
  • Kavi Asset Management first reported a position in Allergan plc in Q4 2015 and held it in 2 quarters.
  • Kavi Asset Management's Allergan plc position peaked at $7.78M in Q4 2015.
  • 1,107 funds tracked by Wall St. Rank held Allergan plc as of Q2 2016.

Based on Kavi Asset Management's 13F filing for Q2 2016, filed 12 Aug 2016.